Dispositivo intrauterino liberador de levonorgestrel (DIU Mirena®) y miomas. Efectos clínicos

J. López-Olmos1
1Unidad de Ginecología, Centro de Especialidades de Monteolivete, Valencia, España

Tài liệu tham khảo

Islam, 2013, Uterine leiomyoma: available medical treatments and new possible therapeutic options, J Clin Endocrinol Metab, 98, 921, 10.1210/jc.2012-3237 Divakar, 2008, Asymptomatic uterine fibroids, Best Pract Res Clin Obstet Gynecol, 22, 643, 10.1016/j.bpobgyn.2008.01.007 Lopez-Olmos, 2014, Dispositivo intrauterino liberador de levonorgestrel (DIU Mirena®) y quistes de ovario, Clin Invest Ginecol Obstet, 41, 9 Gupta, 2013, Levonorgestrel intrauterine system versus medical therapy for menorrhagia, N Engl J Med, 368, 128, 10.1056/NEJMoa1204724 Gorgen, 2009, Use of the levonorgestrel-IUS in the treatment of menorrhagia: Assessment of quality of life in Turkish users, Arch Gynecol Obstet, 279, 835, 10.1007/s00404-008-0834-x Blumenthal, 2011, Cost-efectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system, Int J Gynecol Obstet, 112, 171, 10.1016/j.ijgo.2010.08.025 Hurskainen, 2001, Quality of life and cost-efectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: A randomised trial, Lancet, 357, 273, 10.1016/S0140-6736(00)03615-1 HeliÖvaara-Peippo, 2013, Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: A 10-year randomized controlled trial, Am J Obstet Gynecol, 209, e1, 10.1016/j.ajog.2013.08.041 Hernandez Rivas, 2007, Mirena y miomas en el DIU hormonal. Guía compendio sobre el dispositivo intrauterino de levonorgestrel, Mirena®, Aula Médica, Madrid, 58 Soysal, 2005, The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: A prospective controlled trial, Gynecol Obstet Invest, 59, 29, 10.1159/000080932 Magalhaes, 2007, Uterine volumen and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas, Contraception, 75, 193, 10.1016/j.contraception.2006.11.004 Gunes, 2008, The effect of levonorgestrel intauterine system on uterine myoma: A 1 year follow-up study, J Min Invasiv Gynecol, 15, 735, 10.1016/j.jmig.2008.08.011 Tasci, 2009, Treatment of menorrhagia with the levonorgestrel -releasing intrauterine system: Effects on ovarian function and uterus, Arch Gynecol Obstet, 280, 39, 10.1007/s00404-008-0871-5 Socolov, 2011, Levonorgestrel releasing intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma, Eur J Contracept Reprod Health Care, 16, 480, 10.3109/13625187.2011.614028 Kriplani, 2012, Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma, Int J Gynecol Obstet, 116, 35, 10.1016/j.ijgo.2011.07.031